Meindert Danhof

19.4k total citations
496 papers, 15.3k citations indexed

About

Meindert Danhof is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Meindert Danhof has authored 496 papers receiving a total of 15.3k indexed citations (citations by other indexed papers that have themselves been cited), including 136 papers in Molecular Biology, 116 papers in Cellular and Molecular Neuroscience and 109 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Meindert Danhof's work include Neuroscience and Neuropharmacology Research (86 papers), Receptor Mechanisms and Signaling (71 papers) and Epilepsy research and treatment (68 papers). Meindert Danhof is often cited by papers focused on Neuroscience and Neuropharmacology Research (86 papers), Receptor Mechanisms and Signaling (71 papers) and Epilepsy research and treatment (68 papers). Meindert Danhof collaborates with scholars based in Netherlands, United Kingdom and United States. Meindert Danhof's co-authors include Elizabeth C. M. de Lange, Catherijne A. J. Knibbe, D. D. Breimer, Oscar Della Pasqua, Bart A. Ploeger, Jaap W. Mandema, Piet H. van der Graaf, Ashraf Yassen, Albert Dahan and D.D. Breimer and has published in prestigious journals such as The Lancet, Journal of the American College of Cardiology and Nature Reviews Drug Discovery.

In The Last Decade

Meindert Danhof

493 papers receiving 14.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Meindert Danhof 3.5k 3.3k 2.7k 2.4k 2.3k 496 15.3k
Karen L. Goa 3.0k 0.9× 1.4k 0.4× 2.4k 0.9× 854 0.4× 1.1k 0.5× 282 19.1k
Andrew A. Somogyi 1.3k 0.4× 1.7k 0.5× 2.1k 0.8× 2.1k 0.9× 1.3k 0.6× 253 9.1k
Kim Brøsen 1.8k 0.5× 1.8k 0.5× 2.4k 0.9× 4.8k 2.0× 712 0.3× 233 11.0k
Rex N. Brogden 3.4k 1.0× 1.3k 0.4× 3.5k 1.3× 1.2k 0.5× 1.5k 0.6× 239 18.1k
Nicholas H. G. Holford 1.5k 0.4× 3.3k 1.0× 3.0k 1.1× 1.8k 0.8× 649 0.3× 210 12.9k
Chin B. Eap 1.4k 0.4× 1.9k 0.6× 1.7k 0.6× 2.5k 1.0× 731 0.3× 288 9.2k
Gerd Geißlinger 8.1k 2.3× 1.7k 0.5× 5.9k 2.2× 2.5k 1.1× 3.3k 1.4× 591 24.1k
Jürgen Drewe 3.0k 0.9× 1.5k 0.5× 1.1k 0.4× 989 0.4× 1.4k 0.6× 306 15.3k
Danny D. Shen 1.6k 0.5× 3.3k 1.0× 1.2k 0.4× 3.7k 1.6× 516 0.2× 223 12.1k
Jürgen Brockmöller 4.0k 1.2× 2.7k 0.8× 1.6k 0.6× 5.1k 2.1× 689 0.3× 236 13.8k

Countries citing papers authored by Meindert Danhof

Since Specialization
Citations

This map shows the geographic impact of Meindert Danhof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meindert Danhof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meindert Danhof more than expected).

Fields of papers citing papers by Meindert Danhof

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meindert Danhof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meindert Danhof. The network helps show where Meindert Danhof may publish in the future.

Co-authorship network of co-authors of Meindert Danhof

This figure shows the co-authorship network connecting the top 25 collaborators of Meindert Danhof. A scholar is included among the top collaborators of Meindert Danhof based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meindert Danhof. Meindert Danhof is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taneja, Amit, An Vermeulen, Dymphy Huntjens, et al.. (2017). Modeling of prolactin response following dopamine D2receptor antagonists in rats: can it be translated to clinical dosing?. Pharmacology Research & Perspectives. 5(6). 2 indexed citations
2.
Teutonico, Donato, Flora T. Musuamba, Hugo Maas, et al.. (2015). Generating Virtual Patients by Multivariate and Discrete Re-Sampling Techniques. Pharmaceutical Research. 32(10). 3228–3237. 31 indexed citations
3.
Westerhout, Joost, Dirk‐Jan van den Berg, Robin Hartman, Meindert Danhof, & Elizabeth C. M. de Lange. (2014). Prediction of methotrexate CNS distribution in different species – Influence of disease conditions. European Journal of Pharmaceutical Sciences. 57. 11–24. 44 indexed citations
4.
Krekels, Elke H. J., Dick Tibboel, Saskia N. de Wildt, et al.. (2014). Evidence-Based Morphine Dosing for Postoperative Neonates and Infants. Clinical Pharmacokinetics. 53(6). 553–563. 55 indexed citations
5.
Wang, Chenguang, Karel Allegaert, Mariska Y. M. Peeters, et al.. (2013). The allometric exponent for scaling clearance varies with age: a study on seven propofol datasets ranging from preterm neonates to adults. British Journal of Clinical Pharmacology. 77(1). 149–159. 46 indexed citations
6.
Cock, Roosmarijn F. W. De, Catherijne A. J. Knibbe, Aida Kulo, et al.. (2012). Developmental pharmacokinetics of propylene glycol in preterm and term neonates. British Journal of Clinical Pharmacology. 75(1). 162–171. 27 indexed citations
7.
Muller, Anouk E., P. Joep Dörr, Johan W. Mouton, et al.. (2008). The influence of labour on the pharmacokinetics of intravenously administered amoxicillin in pregnant women. British Journal of Clinical Pharmacology. 66(6). 866–874. 15 indexed citations
8.
Muller, Anouk E., Joost DeJongh, Paul M. Oostvogel, et al.. (2007). Amoxicillin pharmacokinetics in pregnant women with preterm premature rupture of the membranes. American Journal of Obstetrics and Gynecology. 198(1). 108.e1–108.e6. 17 indexed citations
9.
Rolan, Paul, Meindert Danhof, Donald Stanski, & Carl C. Peck. (2006). Current issues relating to drug safety especially with regard to the use of biomarkers: A meeting report and progress update. European Journal of Pharmaceutical Sciences. 30(2). 107–112. 7 indexed citations
10.
Winter, Willem de, Joost DeJongh, Teun M. Post, et al.. (2006). A Mechanism-based Disease Progression Model for Comparison of Long-term Effects of Pioglitazone, Metformin and Gliclazide on Disease Processes Underlying Type 2 Diabetes Mellitus. Journal of Pharmacokinetics and Pharmacodynamics. 33(3). 313–343. 112 indexed citations
11.
Swart, Eleonora L., et al.. (2006). Population pharmacodynamic modelling of lorazepam- and midazolam-induced sedation upon long-term continuous infusion in critically ill patients. European Journal of Clinical Pharmacology. 62(3). 185–194. 23 indexed citations
12.
Prins, Sandra, Mariska Y. M. Peeters, Robert Jan Houmes, et al.. (2005). Propofol 6% as sedative in children under 2 years of age following major craniofacial surgery. British Journal of Anaesthesia. 94(5). 630–635. 14 indexed citations
13.
Swart, Eleonora L., Joost de Jongh, Klaas P. Zuideveld, et al.. (2005). Population pharmacokinetics of lorazepam and midazolam and their metabolites in intensive care patients on continuous venovenous hemofiltration. American Journal of Kidney Diseases. 45(2). 360–371. 36 indexed citations
14.
Rowland, Mary M., L. P. Balant, Meindert Danhof, et al.. (1997). The Population Approach: Measuring and Managing Variability in Response, Concentration and Dose, Commission of the European Community, Luxembourg. Research Explorer (The University of Manchester). 4 indexed citations
15.
Danhof, Meindert, et al.. (1992). Pharmacokinetic Considerations on Orgaran (Org 10172) Therapy. Pathophysiology of Haemostasis and Thrombosis. 22(2). 73–84. 50 indexed citations
16.
Boer, Anthonius de, et al.. (1991). Influence of Chlorthalidone on the Pharmacokinetics and Pharmacodynamics of Org 10172 (Lomoparan®), A Low Molecular Weight Heparinoid, in Healthy Volunteers. The Journal of Clinical Pharmacology. 31(7). 611–617. 5 indexed citations
17.
Boer, Angela G. E. M. de, et al.. (1991). Studies of interaction of a low-molecular-weight heparinoid (Org 10172) with cloxacillin and ticarcillin in healthy male volunteers. Antimicrobial Agents and Chemotherapy. 35(10). 2110–2115. 3 indexed citations
18.
Boer, Angela G. E. M. de, et al.. (1991). Interaction Study between Org 10172, a Low Molecular Weight Heparinoid, and Acetylsalicylic Acid in Healthy Male Volunteers. Thrombosis and Haemostasis. 66(2). 202–207. 7 indexed citations
19.
Boer, Anthonius de, et al.. (1990). Interaction of the Combined Medication with the New Low-Molecular-Weight Heparinoid Lomoparan® (Org 10172) and Acenocoumarol. Pathophysiology of Haemostasis and Thrombosis. 20(3). 136–146. 2 indexed citations
20.
Dingemanse, Jasper, Martine Polhuijs, & Meindert Danhof. (1988). Altered pharmacokinetic-pharmacodynamic relationship of heptabarbital in experimental renal failure in rats.. Journal of Pharmacology and Experimental Therapeutics. 246(1). 371–376. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karen L. Goa Breakdown of academic impact, for papers by Andrew A. Somogyi Breakdown of academic impact, for papers by Kim Brøsen Breakdown of academic impact, for papers by Rex N. Brogden Breakdown of academic impact, for papers by Nicholas H. G. Holford Breakdown of academic impact, for papers by Chin B. Eap Breakdown of academic impact, for papers by Gerd Geißlinger Breakdown of academic impact, for papers by Jürgen Drewe Breakdown of academic impact, for papers by Danny D. Shen Breakdown of academic impact, for papers by Jürgen Brockmöller
Rankless by CCL
2026